The Times has featured the collaborative work of the North East Innovation Lab with Nanovery on nanorobotics.
Nanovery has developed a novel nanorobot detection system for nucleic acids that can detect DNA and RNA with minimal sample pre-processing.
Their DNA nanorobot platform can detect biomarkers directly in blood samples in under two hours, a process typically requiring multiple steps and taking many hours or even days. With applications ranging from diagnosing liver or kidney issues to cancer, this system has the potential to significantly improve access to screening across a wide range of healthcare settings.
Health correspondent Poppy Koronka has written an in-depth innovation feature ‘How robots smaller than a blood cell could help treat cancer’.
The piece includes interviews with Tony Young, national clinical lead for innovation for NHS England, Jerzy (Jurek) Kozyra, chief executive of Nanovery and our very own Dr John Tyson head of the North East Innovation Lab.
It examines how these tiny formations of ‘DNA origami’ containing active molecules can be released into the body to carry out ‘intelligent drug delivery’ and what that could mean for NHS diagnosis and treatment.
Potential applications include early diagnosis of cancer, liver disease and other illness where it is key to find out early and be able to predict outcomes to shape more targeted, accurate and faster treatment.
You can read the full story in The Times app.
Find out more about the innovation lab team’s work with nanorobotics here.
